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ABSTRACT
Background: Mammary tumours represent about 50 to 70% of all neoplasms in female dogs and their occurrence is directly 
related to the reproductive status and patient´s age. The purpose of this research was to apply the Brazilian consensus on 
diagnosis, prognosis and treatment of canine mammary tumours and to define the regional epidemiological aspects of 
canine mammary gland tumours in Vitoria metropolitan region (ES, Brazil) between 2012 and 2016 and to correlate the 
macroscopic characteristics such as lesion size and location of the neoplasm with histopathological diagnosis, tumours 
grade and lymph node metastasis. 
Materials, Methods & Results: Data were collected from the archives of the Laboratory of Animal Pathology of UVV and 
medical records of patients attended at the Veterinary Hospital Prof. Ricardo Alexandre Hippler in 5 years (2012 to 2016). The 
animals were separated into groups by age to facilitate classification in the group with the highest occurrence of neoplasms. The 
evaluation of the macroscopic characteristics was performed through the histopathological record described in the pathology 
laboratory, for each patient, at the time of the initial evaluation. After descriptive analysis, data was correlated using Spearmann 
test, and frequency dispersion was evaluated using chi-square test, both in the software Graph Pad Prism v. 6.01. This study 
included 255 bitches and diagnosis of 486 lesions, once 48.6% of the dogs had more than one lesion, classified according to 
the Brazilian Consensus for Canine Mammary Tumours and graded according to Elston and Ellis system. 86.8% of lesions 
were consistent with actual mammary neoplasms, of which 67% were malignant and 20% were benign. Non-neoplastic lesions 
corresponded to 7.2% of cases and 5.8% were extra-mammary neoplasms, with an increased incidence of lipomas (39.3%) and 
mast cell tumours (32.1%). Cross-breed dogs represented 26.7% of cases. Poodles (25.5%), Pinschers (9.8%) and Dachshund 
(4.7%) were overrepresented. Among mammary glands, inguinal and caudal abdominal were the most affected with 30.8% 
and 25.4%, respectively. Regarding the histopathological grade, 43.7% of the malignant mammary gland tumours were grade I, 
40% grade II and 16.2% grade III. The neoplasms smaller than 3 cm in diameter, corresponded to 43.7% malignant neoplasms, 
of which 75 corresponded to grade I. Those larger or equal to 3-5 cm in diameter corresponded to 22.1% malignant neoplasm, 
of which 31 corresponded to grade II, and those larger than 5 cm in diameter corresponded to 25.8% malignant neoplasms, of 
which 34 corresponded to grade II. Macroscopic ulceration was reported in 35/486 neoplasms; of these, 85.7% were malignant. 
Microscopically necrosis was evidenced in 11.7% of malignant neoplasms and there was a weak, positive correlation between 
the occurrence of necrosis and ulceration (P < 0.0001; rs = 0.223), which was also correlated with tumour size and histological 
grade. Of these patients, 24.4% had metastases, and of these, 8.8% presented macroscopic abnormalities in the lymph node. 
Discussion: Older dogs are at higher risk of developing malignant mammary gland tumour when compared to young 
bitches, most neoplasms with a histopathological grade III occurred in animals older than 10 years, in agreement with the 
literature. Age increasing might be related to more biologically aggressive mammary gland tumours. Early neutering is 
commonly recommended to prevent proliferative abnormalities in the mammary glands, but it has been related to several 
disorders, and neoplasms, in some breeds. Multiple tumours in more than one mammary gland with different histopatho-
logical diagnoses among them, isn’t related to multicentric disease or worse prognosis, as also seen in this survey. Among 
mammary glands, the inguinal and caudal abdominal are often the most affected, as it was observed in this study; however, 
no differences were observed in the occurrence of malignant neoplasms, benign or non-neoplastic. 
Keywords: oncology, dogs, histopathology, breast cancer.
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INTRODUCTION
Mammary gland tumours are very common 
in dogs and cats [14], representing the second most 
frequent tumor in dogs, and the third in cats [4]. This 
occurrence is directly related to the reproductive status 
and patient´s age [19,14]. 
Hormonal influences (mainly ovarian), obesity at 
a young age, fat or animal protein intake [7] were asso-
ciated with an increased risk of developing breast cancer 
in bitches and women [4,14,33]. Spaying has a protec-
tive effect on the development of mammary tumours 
in bitches. It was found that the risk reduces to 0.5%, 
8% and 26% if neutering is performed before the first, 
second and third oestral cycles, respectively [14,24,42]. 
Spaying after the fourth oestrus does not reduce the risk 
of developing breast neoplasia in this specie [14].
Surgery is the treatment of choice for all dogs 
with mammary tumours, except for inflammatory 
carcinoma [19,35] and the surgical techniques include 
lumpectomy or nodulectomy, simple mastectomy, 
regional mastectomy, or radical mastectomy [19]. The 
final diagnoses are only obtained after histopatholo-
gical examination, usually performed after surgery.
The number of dogs presenting with mammary 
gland tumours is apparently high in Vitória metropo-
litan region, ES, Brazil, however regional epidemio-
logical characteristics remain unknown. This study 
aimed to apply the Brazilian consensus [5] and define 
the regional epidemiological aspects of mammary 
gland tumours between 2012 and 2016 and to correlate 
the macroscopic characteristics such as lesion size 
and location of the neoplasm with histopathological 
diagnosis, tumour grade and lymph node metastasis.
MATERIALS AND METHODS
Animals
This study is a clinical and histopathological 
survey of bitches submitted to surgical treatment at the 
Veterinary Hospital Prof. Ricardo Alexandre Hippler 
and diagnosed by the Laboratory of Animal Pathology, 
at UVV, ES (Brazil) between 2012 to 2016.
Medical records were reviewed for patient´s 
identification (breed, sex, reproductive status and age). 
The animals were separated into groups by age (less 
than 3 year-old - young, 3 to 8 - adults, and above 8 
year-old - elderly) to facilitate classification in the 
group with the highest occurrence of neoplasms. 
Histopathology
Histopathological sections stained with hema-
toxylin and eosin were reviewed by optic microscopy. 
The classification was performed as proposed 
by Cassali et al. [5]. Histological grading was perfor-
med according to Elston and Ellis [9] grading system, 
by scoring, the amount of tubular formation, nuclear 
pleomorphism and number of mitoses in 10 random 
high-power-fields (400x). 
Statistical analysis
After descriptive analysis, data was correlated 
using Spearmann test, and frequency dispersion was 
evaluated using chi-square test, both in the software 
Graph Pad Prism v. 6.01. Differences were conside-
red significative if P < 0.05. Significant correlations 
were considered weak when it occurred in less than 
9% of the studied population (rs < 0.3), moderate if it 
occurred in 9 to 49% of the studied cases (0.3 < rs < 
0.7) and strong if it occurred in more than 49% of the 
population (rs > 0.7).
RESULTS
This study included 255 bitches and diagnosis 
of 486 mammary lesions (mean of 2.2 lesions per dog), 
once 48.6% (109/255) of the dogs had more than one 
lesion. Cross-breed dogs represented 26.7% of cases 
(68/255). Poodles (25.5%), Pinschers (9.8%) and Da-
chshund (4.7%) were overrepresented. 
Age was reported in 93.3% of the dogs 
(238/255) and ranged from 2 to 16 years (10.2 ± 2.8). 
Most neoplasms occurred in bitches older than 8 years, 
representing 61.6% of cases (157/238). Dogs with 3 to 
8 year-old, represented half of it (31% of cases, 79/238) 
and those with less than 3 year-old represented only 
0.8% (2/238) [Figure 1].
Spearmann test, revealed a weak, but positive 
correlation of age, with the development of malignant 
neoplasms (P = 0.01; rs = 0.118) higher histological 
grades (P = 0.002; rs = 0.146), occurrence of necrosis 
(P = 0.04, rs = 0.096) and lymph node metastasis (P 
= 0.03; rs = 0.123). Chi-square test also revealed a 
greater tendency of developing malignant neoplasms 
in animals older than eight years (P = 0.04) [Table 1]. 
In this study, 87% of lesions (423/486) were 
consistent with actual mammary neoplasms, of which 
67% (326/486) were malignant and 20% (97/486) 
were benign. Non-neoplastic lesions corresponded 
to 7.2% of cases (35/486) and 5.8% (28/486) were 
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extra-mammary neoplasms (lipoma, acantholytic epi-
dermoid carcinoma, mast cell tumour, angiolipoma, 
fibropapilloma, histiocytoma, collagenous hamar-
toma, cavernous hemangioma), with an increased 
incidence of lipomas (39.3%) and mast cell tumours 
(32.1%) [Figure 2]. 
Non-neoplastic breast lesions constituted 
35/486 cases (7.2%), with a higher incidence of ductal 
ectasia (37.1%, 13/35) and lobular hyperplasia (11.4%, 
4/35). The most frequent benign neoplasms were the 
tubular adenoma (45.4%, 44/97) and benign mixed 
tumor (28.9%, 28/97) [Table 2].  
Malignant neoplasms were composed of 
292/326 (89.57%) carcinomas, 8/326 (2.45%) carci-
nossarcomas, and 26/326 (7.97%) other histological 
types (special types and sarcomas). The most frequent 
carcinoma was the carcinoma in mixed tumour (57.8%, 
188/326), followed by tubular carcinoma (15.1%, 
49/326). Regarding the histological grade, 43.6% of 
the malignant mammary gland tumours were grade I 
(142/326), 39.9% grade II (130/326) and 16.3% grade 
III (53/326) [Table 3]. 
According to the size, neoplasms smaller than 
3 cm in diameter corresponded to 143/326 malignant 
neoplasms, of which 74 corresponded to grade I. Those 
larger or equal to 3-5 cm in diameter corresponded 
to 72/326 malignant neoplasm, and of these, 31 were 
grade II tumours, and those larger than 5 cm in diameter 
corresponded to 84/326 malignant neoplasms, of which 
34 were classified as a grade II (Table 4). According 
to the Spearmann’s test, tumour size also correlated 
positively, although weakly, with malignant neoplasms 
(P = 0.002; rs = 0.203), with higher histopathological 
grade (P < 0.0001, rs = 0.146) ulceration (P < 0.0001; 
rs = 0.129), and metastasis in the lymph nodes (P = 
0.002; 0.175). Spearmann test also revealed a positive 
correlation of the histopathological grade with tumour 
size (P < 0.0001, rs = 0.265), occurrence of necrosis 
(P < 0.0001, rs = 0.233) and ulceration (P < 0.0001, rs 
= 0.363). The correlations were weak for tumour size 
and occurrence of necrosis, but moderate for ulcera-
tion. Mammary glands inguinal and caudal abdominal 
were more affected, 30.8% and 25.4%, respectively. 
Unfortunately, in this study it was possible to identify 
the information of the reproductive status before the 
diagnosis only in 47.8% (122/255) dogs. 5.9% of dogs 
(15/255) were spayed before diagnoses of mammary 
tumor, and most of them had malignant neoplasms 
(12/15). However, it was not possible to tell at what age 
these bitches were neutered. Spaying was performed, 
along with mastectomy in 34.9% of dogs (89/255).
DISCUSSION
The genes BRCA1 and BRCA2 are known as 
important risk factors for the development of breast 
neoplasia in humans, and they were also associated 
with the high risk of developing mammary tumours in 
Cocker Spaniel [3,27,28,42], although this breed was 
not prevalent in this study. Breed predisposition is not 
well established in the literature, since the difference 
may be related to the profile of the canine population 
at each survey. However, the incidence was similar to 
what is described by other authors [17,25,39].
Most neoplasms occurred in bitches older than 
eight years, as described in the literature [10,24]. Mam-
mary gland tumours occur mainly in dogs between 7 
and 13 year-old, and it is considered rare in young 
animals, with less than 4 year-old [14,19]. The relative 
risk increased from 1% to 6% and 13% in bitches with 
6, 8 and 10 years, respectively [8], although large-breed 
dogs may develop it at a younger age [14].
Spearmann test and Chi-square test, revealed 
on this study, a greater tendency of developing ma-
lignant neoplasms in animals older than eight years, 
as evidenced by another studies [4,14,18,39]. Aging 
results in a greater probability of genetic mutations 
accumulation, and the detection and elimination of 
these cells by immune mechanisms occur less effecti-
vely [34]. Progression of hyperplasic or benign lesions 
to malignancies may take several months [14], which 
leads to such difference in frequency dispersion of 
benign or malignant mammary gland tumours in dogs, 
according to age.
The influence of ovarian hormones on the 
initiation and progression of breast neoplasms is well 
studied through the expression of oestrogen and pro-
gesterone receptors in mammary tissue [21]. Prolactin, 
oestrogen and progesterone receptors are expressed in 
high concentrations in the normal mammary gland, but 
reduced in adenomas and, especially, in carcinomas 
[20,38]. These hormones, especially when the animal 
receives exogenous progestogens, induce dysplastic 
and hyperplastic changes that can progress to benign 
and malignant neoplasms, with subsequent loss of 
hormonal dependence, from the moment the process 
becomes autonomous [14]. 
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Figure 1. Mammary gland tumours by age in 255 dogs. Most neoplasms 
occurred in bitches older than eight years, representing 157/238 of cases, 
followed by cases with 3 to 8 years (79/238) and less than 3 years old 
(2/238). N/I: Not informed age. 
Figure 2. Distribuition of 486 mammary lesions in 255 dogs; which 422 
were mammary neoplasms: 326/486 were malignant and 97/486 were 
benign. Non-neoplastic lesions corresponded to 35/486 of cases and 
28/486 were extra-mammary neoplasms. *Lipoma, acantholytic epidermoid 
carcinoma, mast cell tumours, angiolipoma, fibropapilloma, histiocytoma, 
collagenous hamartoma, cavernous hemangioma.
Table 1. Ocurrence from 2012 to 2016 of non-neoplastic, benign and malignant mammary gland tumours in 255 female dogs, and tu-





















< 3 2 (0.4) 0 0 1 (1) 1 (0.3) 0 0 1 (1.9)
3 to 8 132 (27.2) 16 (45.7) 10 (35.7) 29 (29.9) 76 (23.4) 38 (26.8) 32 (24.6) 6 (11.3)
> 8 319 (65.6) 18 (51.4) 15 (53.6) 59 (60.8) 228 (69.9) 87 (61.3) 94 (72.3) 46 (86.8)
N/I* 33 (6.8) 1 (2.6) 3 (10.7) 8 (8.2) 21 (6.5) 14 (9.9) 4 (3.1) 3 (5.7)
Total 486 (100) 35 (100) 28 (100) 97 (100) 326 (100) 142 (100) 130 (100) 53 (100)
*
 Not informed age.
The use of oestradiol ciprionate, as an abortive 
drug, is associated with ductal growth, although no 
increase in the incidence of breast tumours has been re-
ported in dogs [19,21]. The use of synthetic progestins, 
such as megestrol acetate and medroxyprogesterone 
acetate, to prevent oestrus, is associated with lobe-
-alveolar development, with hyperplasia of the secre-
tory and myoepithelial elements [22], and low doses 
of this hormone predisposes the formation of benign 
neoplastic nodules [14,21]. The combination of oes-
trogen and progesterone, especially when performed 
for long periods and in high doses, seems to induce the 
development of malignant breast neoplasms [14,30].
Therefore, early neutering is commonly re-
commended to prevent proliferative abnormalities in 
the mammary glands.
Nevertheless, early neutering has been related to 
several disorders [1,26,29,37]. It may impair development 
of external genitalia and skeletal growth, along with a 
greater risk of obesity, which might result in an increased 
risk of coxofemoral dysplasia, elbow dysplasia, and / or 
cranial cruciate ligament rupture, as well an increased 
risk of adrenal gland dysfunction, urinary incontinence, 
behavioural changes, hypothyroidism, epilepsy, and an 
onset of neoplasms, such as osteosarcoma, mainly in the 
Rottweiler [6]; transitional cell carcinoma of the bladder, 
mainly in the Scottish Terrier [26]; cutaneous mast cell 
tumor in Boxers, Labrador Retrievers, Golden Retrievers 
and Pugs [41]. Besides mast cell tumours, hemangiosarco-
ma and lymphoma were associated with neutering (early 
or late) in males and female Golden Retrievers [16,40]. 
Pseudocyesis is related to an early onset and 
higher development of malignant mammary gland 
tumours [25]. It is often observed in bitches due to 
prolonged duration of luteal phase, which leads to high 
concentrations of serum progesterone and consequen-
tly mammary development, followed by oestrogen 
and prolactin production. The intensity and duration 
of oestrogen and prolactin exposure in the mammary 
gland increases the risk of mammary cancer [33]. Pro-
lactin facilitates the pro-mitotic action of oestrogen by 
increasing the expression of its receptors [11,33]. The 
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pseudocyesis was informed in 24 clinical files (24/255), 
of which 18 (7.06%) presented this pathology, and due to 
insufficient data, it was not possible to correlate it with 
the incidence of mammary gland tumours.
Among mammary glands, the inguinal and 
caudal abdominal (M5 and M4) are often the most 
affected [10,14,23,39], as it was observed in this study, 
representing 30.8% and 25.4% of mammary gland 
tumours, respectively. The explanation for the greater 
frequency of this location is that these glands present 
a greater amount of mammary parenchyma, and, the-
refore, an increased number of hormonal receptors 
[14,36]. However, no differences were observed in the 
occurrence of malignant neoplasms, benign or non-
-neoplastic, by the chi-square test (P = 0.4) and there 
was no correlation with the other studied variables.
In this study, 48.6% (109/255) of the dogs had 
more than one lesion, and 85% of dogs (217/255) had 
at least one malignant mammary gland tumour. These 
results are similar to those described by other surveys 
[2,12,17], in which 60% of the dogs presented multiple 
tumours in more than one mammary gland with diffe-
rent histopathological diagnoses among them, although 
these is not be related to multicentric disease or worse 
prognosis [35]. Cassali [4] states that about 50% of breast 
neoplasms are benign and that carcinomas correspond 
to approximately 45%. Nevertheless, in this study, the 
distribution of lesions was similar to what is reported by 
other Brazilian studies, with an incidence of malignancies 
exceeding 60%, probably due to the delay in the search 
for veterinary assistance [10,11,17,24], and transforma-
tion of benign mixed tumor into in situ or invasive lesions 
[5]. First world countries reveal a different picture with an 
incidence of malignancy between 41 to 53% [11,19,31]. 
The most frequent benign neoplasms were the 
tubular adenoma (45.4%, 44/97) and benign mixed 
tumour (28.9%, 28/97) [Table 2], which differs from 
Horta et al. [17], in Belo Horizonte (MG, Brazil), that 
showed a higher frequency of benign mixed tumour. 
Among the malignant neoplasms the most fre-
quent was the carcinoma in mixed tumour according to 
the Brazilian classification [5], which corroborates the fin-
Table 2. Non-neoplastic lesions and benign neoplasms diagnosed in 255 female dogs between 2012 at 2016 at the Laboratory of Animal Pathology, 
Universidade Vila Velha, ES, Brazil.
Non-neoplastic epithelial lesion Frequency (%) Necrosis (%) Ulceration (%)
Adenosis 1 (2.9) 0 0
Epithelial hyperplasia: 3 (8.6) 0 0
Atypica 1 (2.9) 0 0
Columnar 3 (8.6) 0 0
Lobular 4 (11.4) 0 0
Lobular with atypia 1 (2.9) 0 0
Tubular 2 (5.7) 0 0
Epitheliosis 1 (2.9) 0 0
Duct ectasia 13 (37.1) 0 0
Nipple ectasia 2 (5.7) 0 0
Reactive mammary gland 2 (5.7) 0 0
Sudoripal gland ectasia 1 (2.9) 0 0
Tubular ectasia 1 (2.9) 0 0
Benign Tumors    
Benign mixed 27 (27.8) 0 0
Complex adenoma 14 (14.4) 0 0
Ductal papilloma 5 (5.2) 0 0
Fibroadenoma 7 (7.2) 0 1 (33.3)
Tubular adenoma 44 (45.4) 2 (100) 2 (66.7)
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Table 4. Frequency of mammary gland tumors, malignancy and histopathological grade, according to tumour size diagnosed in the 
period of 2012 to 2016 at the Laboratory of Animal Pathology, Universidade Vila Velha, ES, Brazil.
Size Frequency (%) Malignancy (%) Grade I (%) Grade II (%) Grade III (%)
T1 (<3 cm) 238 (49) 143 (43.8) 74 (53.2) 53 (40.8) 15 (25.4)
T2 (3-5 cm) 95(19.5) 72 (22.1) 27 (19.4) 31 (23.8) 16 (27.1)
T3 (>5 cm) 106 (21.8) 84 (25.7) 25 (18) 34 (26.2) 25 (42.4)
N/I* 47 (9.7) 27 (8.2) 13 (9.4) 12 (9.2) 3 (5.1)
Total 486 (100) 326 (100) 139 (100) 130 (100) 59 (100)
*Not informed size.
Table 3. Malignant mammary neoplasms diagnosed in 255 female dogs between 2012 and 2016 at the Laboratory of Animal Pathology, 














In mixed tumour 188 (57.8) 87 (61.3) 82 (63.1) 19 (35.8) 40 (44.4) 17 (44.7) 10 (33.3)
Ductal in situ 6 (1.8) 4 (2.8) 2 (1,5) 0 1 (1.1) 0 0
comedo 2 (0.6) 1 (0.7) 0 1 (1,9) 1 (1.1) 1 (2.6) 0
cribiform pattern 1 (0.3) 0 0 1 (1,9) 1 (1.1) 0 1 (3.3)
micropapillary 1 (0.3)  0 1 (0.8) 0 1 (1.1) 0 0
papillary 11 (3.4) 5 (3.5) 6 (4.6) 0 2 (2.2) 1 (2.6) 3 (10)
solid 1 (0.3) 1 (0.7) 0 0 0 0 0
Papillary 11 (3.4) 5 (3.5) 6 (4.6) 0 2 (2.2) 0 0
invasive 2 (0.6) 1 (0.7) 1 (0.8) 0 1 (1.1) 0 0
non-invasive 1 (0.3) 1 (0.7) 0 0 0 0 0
Solid 19 (5.8) 4 (2.8) 6 (4.61) 9 (17) 6 (6.6) 8 (21.1) 4 (13.3)
Tubular 49 (15.1) 28 (19.7) 18 (13.8) 3 (5,7) 19 (21.1) 2 (5.3) 4 (13.3)
Special Type        
Anaplastic 5 (1.5) 0 3 (2.3) 2 (3.8) 3 (3.4) 0 0
Basal cell 1 (0.3) 1 (0.7) 0 0 1 (1.1) 0 1 (3.3)
Invasive lobular 1 (0.3) 0 0 1 (1.9) 1 (1.1) 0 1 (3.3)
Lipid-rich 1 (0.3) 1 (0.7) 0 0 0 1(2.6) 0
Malignant  
adenomyoepithelioma 2 (0.6) 0 0 2 (3.8) 1 (1.1) 2 (5.3) 1 (3.3)
Mammary 1 (0.3) 1 (0.7) 0 0 0 0 0
Micropapillary 3 (0.9) 0 0 3 (5.7) 3 (3.3) 0 1 (3.3)
Spindle-cell 3 (0.9) 1 (0.7) 1 (0.8) 1 (1.9) 1 (1.1) 1 (2.6) 1 (3.3)
Squamous cell 4 (1.2) 0 1 (0.8) 3 (5.7) 2 (2.2) 2 (5.3) 1 (3.3)
Carcinosarcomas 8 (2.5) - - - 4 (4.4) 1 (2.6)  0
Sarcomas
       
Osteosarcoma 2 (0.6) - - - 0 2 (5.3) 1 (2.6)
Undifferentiated 2 (0.6)  -  -  - 0 0 1 (2.6)
Hemangiosarcoma 1 (0.3)  -  -  -  0  0  0
*With sebaceous differentiation.
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dings of earlier studies [10,23], corresponding to 188/326 
(57.7%). Followed by tubular carcinomas, corresponding 
to 15%, (49/326). These results converge with another 
study [14,15] that found a similar prevalence of tubular 
carcinomas (17/63), when using the Brazilian consensus.
The prevalence according to tumour grade 
different from Frehse et al. [13], who reported a higher 
occurrence of grade II tumours. Most neoplasms with 
a histopathological grade III occurred in animals older 
than 10 years (P < 0.0001), and in agreement with the 
literature, age increasing might be related to more bio-
logically aggressive mammary gland tumours [14,18]. 
Chi-square test revealed a higher tendency to 
malignancy and a higher histological grade in T2 (3-5 
cm) and T3 (> 5 cm) lesions compared to T1 (<3 cm) 
lesions, with P = 0.0002 and P = 0.05, respectively, 
as stated by Feliciano et al. [11] and Goldschmidt et 
al. [14]. T2 and T3 lesions also had a higher grade 
compared to T1 lesions, with P = 0.001. The worst 
prognosis occurs in tumours with 3-5 cm in diameter 
[14], however, in the present study, the disease-free in-
terval, overall survival and prognosis of these patients 
were not evaluated.
Macroscopic ulceration was reported in 35/486 
mammary lesions. Of these, 85.7% (30/35) were ma-
lignant. This result was superior to that observed by 
Oliveira et al. [25] who observed that 72.7% of the ul-
cerated tumours corresponded to malignant mammary 
gland tumours, confirming the ulceration as indicative 
of malignancy. Necrosis was evidenced, microscopi-
cally in 11.7% of malignant neoplasms (38/326) and 
there was a weak, positive correlation between the 
occurrence of necrosis and ulceration (P < 0.0001; rs 
= 0.223), which also correlated with tumour size and 
histological grade, as previously described. Necrosis 
also showed a weak, positive correlation with the 
occurrence of lymph node metastasis (P = 0.03; rs = 
0.123), which did not occur for ulceration. However, 
Santos et al. [32] showed no influence of necrosis 
and ulceration on survival and disease-free interval in 
bitches with malignant mammary tumours.
The lymphatic system represents the main pa-
thway for metastasis of malignant mammary tumours 
[5,35], however, only 106 lymph nodes of 217 diagnoses 
with at least one malignant mammary tumour were remo-
ved and identified with histopathological examination, 
due to the surgical technique chosen and the difficulty 
of resection of the axillary lymph nodes in the surgeries 
that involved the resection of the cranial glands. Of these 
patients, 53 (24.4%) had metastases, and 23, 30 and 20 
presented grade I, II and III tumours, respectively. In 
19 patients (8.8%), the lymph node was macroscopic 
enlarged, and in 34 (15.7%) there was no metastasis. 
The limitations of this study were the im-
precision of information about reproductive status 
(pseudocyesis, contraceptive use, and age at which 
ovariohysterectomy was performed), impossibility 
to determine body score, heterogeneity of clinical-
-surgical treatments, and lack of clinical follow-up. 
However, this study allowed the identification of the 
most frequent histological types, according to the 
Brazilian classification [5], in addition to the charac-
terization of prognostic factors already established in 
the literature (tumour size, lymph node involvement, 
histological grade), thus increasing the knowledge 
about the distribution of mammary gland tumours in 
dogs, especially in the Vitória metropolitan region, 
ES, Brazil. 
In this study was possible to identify the infor-
mation of the reproductive status before the diagnosis 
only in 47,8% (122/255) dogs. Fifteen dogs (5,9%) 
were spayed before diagnosis of mammary tumors, 
and most of them had malignant neoplasms (12/15). 
However, it was not possible to tell at what age these 
bitches were neutered. Spaying was performed, along 
eith mastectomy in 34,9% of dogs (89/255).
CONCLUSION
The results of this survey agree with a lot of 
others in the literature, and it represents the first epi-
demiological study of canine mammary tumours in 
Espírito Santo, Brazil. Tumor size, lymph node invol-
vement, histopathological type, tumour grade, ulceration 
and necrosis are crucial information, for clinical and 
pathological approaches to canine mammary neoplasms. 
REFERENCES
1 Arnold S., Hubler M. & Reichler I. 2009. Urinary incontinence in spayed bitches: new insights into the pathophysiol-
ogy and options for medical treatment. Reproduction in Domestic Animals. 44 (2): 190-192.
2 Benjamin S.A., Lee A.C. & Saunders W.J. 1999. Classification and Behavior of Canine Epithelial Neoplasms Based 
on Life-Span Observations in Beagles. Veterinary Pathology. 36: 423-436.
8                                                                                                           H.C. Silva, A.R. Oliveira, R.S. Horta, et al. 2019. Epidemiology of Canine Mammary Gland Tumours in Espírito Santo, Brazil.                  
                                                                                  Acta Scientiae Veterinariae. 47: 1640.
3 Borge K.S., Børresen-Dale A.L. & Lingass F. 2011. Identification of genetic variation in 11 candidate genes of canine 
mammary tumour. Veterinary and Comparative Oncology. 9(4): 241-250.
4 Cassali G.D. 2015. Patologia da Glândula Mamária. In: Nascimento E.F. & Santos R.L. (Eds). Patologia da Reprodução 
dos Animais Domésticos. 3.ed. Rio de Janeiro: Guanabara Koogan, pp.133-115.
5 Cassali G.D., Lavelle G.E., De Nardi A.B., Ferreira E., Bertagnolli A.C., Estrela-Lima A., De Nardi A.B., Ghever 
C., Sobral R.A., Amorim R.L., Oliveira L.O.,  Sueiro F.A.R., Beserra H.E.O., Bertagnolli A.C., Gamba C.O., 
Damasceno K.A., Campos C.B., Araujo M.R., Campos L.C.,  Monteiro L.N., Nunes F.C., Horta R.S., Reis D.C., 
Luvizotto M.C.R., Magalhães G.M., Raposo J.B., Ferreira A.M.R.,  Tanaka N.M., Grandi F., Ubukata R., 
Batschinski K., Terra E.M.,  Salvador R.C.L., Jark P.C., Delecrodi J.E.R., Nascimento N.A.,  Silva D.N., Silva 
L.P., Ferreira K.C.R.S., Frehse M.S.,  Santis G.W., Silva E.O., Guim T.N., Kerr B., Cintra P.P.,  Silva F.B.F., Leite 
J.S., Mello M.F.V., Ferreira M.L.G.,  Fukumasu H., Salgado B.S. & Torres R. 2014. Consensus for the diagnosis, 
prognosis and treatment of canine mammary tumours. Brazilian Journal Veterinary Pathology. 7(2): 38-69.
6 Cooley D.M., Beranek B.C., Schlittler D.L., Glickman M.W., Glickman L.T. & Waters D.J. 2002. Endogenous 
gonadal hormone exposure and bone sarcoma risk. Cancer Epidemiology Biomarkers & Prevention. 11: 1434-1440.
7 De Nardi A.B., Rodaski S., Souza R.S., Costa T.A., Macedo T.R., Rodigheri S.M., Rios A. & Piekarz C.H. 2002. 
Prevalência de neoplasias e modalidades de tratamentos em cães, atendidos no Hospital Veterinário da Universidade 
Federal do Paraná. Archives of Veterinary Science. 7(2): 15-26. 
8 Egenvall A., Bonnet B.N. & Ohagen P. 2005. Incidence and survival after mammary tumours in a population of over 
80,000 insured female dogs in Sweden from 1995 to 2002. Preventive Veterinary Medicine. 69: 109-127.
9 Elston C.W. & Ellis I.O. 1991. Pathological prognostic factors in breast cancer, I: the value of histological grade in 
breast cancer: experience from a large study with long-term follow-up. Histopathology. 19(5): 403-410.
10 Estrela-Lima A., Neto J.M.C., Oriá A.P., Moreira E.L.T., Peixoto TC, Muramoto C., D’assis M.J.M.H., Vieira 
Filho C.H.C., Machado M.C.A., Nascimento N.A., Silva D.N., Martins Filho E.F., Gomes E.A., Silva L.P., Requião 
L.G.T. & Fontes T.N. 2014. Clinical Pathological Study of Mammary Tumours in Female Dogs from the Veterinary 
Hospital of UFBA – Bahia, Brazil. Brazilian Journal Veterinary Pathology. 7(2): 106-143. 
11 Feliciano M.A.R., Silva A.S., Peixoto R.Y.R., Galera P.D. & Vicente W.R.R. 2012. Estudo clínico, histopatológico e 
imunoistoquímico de neoplasias mamárias em cadelas. Arquivo Brasileiro de Medicina Veterinária e Zootecnia. 64(5): 
1094-1100.
12 Fowler E.H., Wilson G.P. & Koester A. 1974. Biologic Behavior of Canine Mammary Neoplasms Based on a His-
togenic Classification. Veterinary Pathology. 11: 212-229. 
13 Frehse M.S., Bracarense A.P.F.R.L., Santis G.W., Silva E.O., Freire R.L., Machado M.A. & Martins M.I.M. 
2014. Epidemiological and Histological Aspects of Canine Mammary Tumours Diagnosed at the Veterinary Teaching 
Hospital/UEL. Brazilian Journal Veterinary Pathology. 7(2): 106-143.
14 Goldschmidt M., Penã L. & Zappulli V. 2017. Tumours of the Mammary Gland. In: Meuten D.J. (Ed). Tumours in 
Domestic Animals. 5th edn. Ames: Wiley-Blackwell, pp.723-765.
15 Gundim L.F., Araújo C.P., Blanca W.T., Guimarães E.C. & Medeiros A.C.A. 2016. Clinical staging in bitches with 
mammary tumours: Influence of type and histological grade. Canadian Journal of Veterinary Research. 80: 318-322.
16 Hart B.L., Hart L.A., Thigpen A.P. & Willits N.H. 2014. Long-term health effects of neutering dogs: Comparison 
of labrador retrievers with golden retrievers. PLoS ONE. 9(7). e102241. doi: 10.1371/journal.pone.0102241.
17 Horta R.S., Lavalle G.E., Cunha R.M.C., Moural L.L., Araújo R.B. & Cassali G.D.C. 2014. Influence of Surgical 
Technique on Overall Survival, Disease Free Interval and New Lesion Development Interval in Dogs with Mammary 
Tumours. Advances in Breast Cancer Research. 3: 38-46.
18 Kim H.W., Lim H.Y., Shin J.I., Seung B.J., Ju J.H. & Sur J.H. 2016. Breed- and age-related differences in canine 
mammary tumours. Canadian Journal of Veterinary Research. 80: 146-155.
19 Lana S.E., Rutteman G.R. & Withrow S.J. 2007. Tumours of the mammary gland. In: Withrow S.J. & MacEwen 
E.G. (Eds). Small Animal Clinical Oncology. 4th edn. Philadelphia: W.B. Saunders Co., pp.619-636.
20 Michel E., Feldmann S.K., Kowalewski M.P., Bley C.R., Boos A., Guscetti F. & Reichler I.M. 2012. Expression 
of prolactin receptors in normal canine mammary tissue, canine mammary adenomas and mammary adenocarcinomas. 
Veterinary Research. DOI: 10.1186/1746-6148-8-72.
9                                                                                                           H.C. Silva, A.R. Oliveira, R.S. Horta, et al. 2019. Epidemiology of Canine Mammary Gland Tumours in Espírito Santo, Brazil.                  
                                                                                  Acta Scientiae Veterinariae. 47: 1640.
1640
http://seer.ufrgs.br/ActaScientiaeVeterinariae
21 Millán Y., Guil-Luna S., Reymundo C., Sánchez-Céspedes R. & Las Mulas J.M. 2013. Sex Steroid Hormones and 
Tumours in Domestic Animals. In: Payan-Carreira R. (Ed). Insights from Veterinary Medicine.   Vila Real: IntechOpen, 
pp.191 -214.
22 Misdorp W. 1991. Progestagens and mammary tumours in dogs and cats. Acta Endocrinologica. 125: 27-31.
23 Nunes F.C., Gamba C.O., Damasceno K.A., Campos C.B., Horta R.S., Araújo M.R., Monteiro L.N., Lavalle G.E., 
Ferreira E. & Cassali G.D. 2014. Analisis of Clinico Pathological Data Therapeutical Conduct and Overall Survival 
of Canine Mammary Lesions Attended at the Veterinary Hospital of the Federal University of Minas Gerais (UFMG). 
Brazilian Journal Veterinarian Pathology. 7(2): 106-143.
24 Oliveira Filho J.C., Kommers G.D., Masuda E.K., Marques B.M.F.P.P., Fighera R.A., Irigoyen L.F. & Barros 
C.S.L. 2010. Estudo retrospectivode 1.647 tumores mamários em cães. Pesquisa Veterinária Brasileira. 30: 177-185.
25 Oliveira L.O., Oliveira R.T., Loretti A.P., Rodrigues R. & Driemeier D. 2003. Aspectos epidemiológicos da neo-
plasia mamária canina. Acta Scientiae Veterinariae. 31(2): 105-110.
26 Reichler I. 2009. Gonadectomy in cats and dogs: a review of risks and benefits. Reprodution in Domestic Animals. 
44(s2): 29-35.
27 Rivera P. 2010. Biochemical Markers and Genetic Risk Factors in Canine Tumours. 82f. Uppsala, SWE. Dissertação 
(Doctoral thesis) Department of Clinical Sciences, Swedish University of Agricultural Sciences. 
28 Rivera P., Melin M., Biagi T., Fall T., Häggström J., Lindblad-Toh K. & Von Euler H. 2009. Mammary tumor 
development in dogs is associated with BRCA1 and BRCA2. Cancer Research. 69: 8770-8774.
29 Romagnoli S. 2017. Early-age neutering in dogs and cats: advantages and disadvantages. Revista Brasileira de Re-
produção Animal. 41(1): 130-132.
30 Rutteman G.R. 1992. Contraceptive steroids and the mammary gland: is there a hazard? Breast Cancer Research and 
Treatement. 23: 29-41.
31 Salas Y., Márquez A., Diaz D.l. & Romero L. 2015. Epidemiological Study of Mammary Tumours in Female Dogs 
Diagnosed during the Period 2002-2012: A Growing Animal Health Problem. PLoS One. 18;10(5): e0127381.
33 Santos A.A., Lopes C.C., Ribeiro J.R., Martins L.R., Santos J.C., Amorim I.F., Gärtner F. & Matos A.J. 2013. 
Identification of prognostic factors in canine mammary malignant tumours: a multivariable survival study. BMC Vet-
erinary Research. 9(1): 1-11.
34 Silva A.E., Serakides R. & Cassali G.D. 2004. Carcinogênese hormonal e neoplasias hormônio-dependentes. Ciência 
Rural. 34(2): 625-633.
35 Sleeckx N., Rooster H., Veldhuis Kroeze E.J.B., Van Ginneken C. & Van Brantegem L. 2011. Canine Mammary 
Tumours, an Overview. Reprodution in Domestic Animals. 46: 1112-1131.
36 Sorenmo K.U. 2003. Canine mammary gland tumours. Veterinary Clinics of North America: Small Animal Practice. 
33: 573-596.
37 Sorenmo K.U., Rasotto R., Zappulli V. & Goldschmidt M.H. 2011. Development, anatomy, histology, lymphatic drainage, 
clinical features, and cell differentiation markers of canine mammary gland neoplasms. Veterinary Pathology. 48(1): 85-97.
38 Spain V.C., Scarlett J.M. & Houpt K.A. 2004. Long-term risks and benefits of early-age gonadectomy in dogs. 
Journal of the American Veterinary Medical Association. 224(3): 380-387.
39 Spoerri M., Guscetti F., Hartnack S., Boos A., Oei C., Balogh O., Nowaczyk R.M., Michel E., Reichle I.M. & 
Kowalewski M.P. 2015. Endocrine control of canine mammary neoplasms: serum reproductive hormone levels and 
tissue expression of steroid hormone, prolactin and growth hormone receptors. BMC Veterinary Research. 11:235.
40 Toríbio J.M.M.L., Lima A.E., Martins Filho E.F., Ribeiro L.G.R., D’assis M.J.H., Teixeira R.G., Damasceno K.A., 
Cassali G.D. & Costa Neto J.M. 2012. Caracterização clínica, diagnóstico histopatológico e distribuição geográfica 
das neoplasias mamárias em cadelas de Salvador, Bahia. Revista Ceres. 59(4): 427-433.
41 Torres De La Riva G., Hart B.L., Farver T.B., 2013. Oberbauer A.M., Messam L.L.M., Willits N. & Hart L.A. 
2013. Neutering Dogs: Effects on Joint Disorders and Cancers in Golden Retrievers. PLoS One. 8(2): e55937.
42 White C.R., Hohenhaus A.E., Kelsey J. & Procter-Grey E. 2011. Cutaneous MCTs: Associations with spay/neuter 
status, breed, body size, and phylogenetic cluster. Journal of the American Animal Hospital Association. 47: 210-216.
43 Zatloukal J., Lorenzová J., Tichý F., Necas A., Kecová H. & Kohout P. 2005. Breed and age as Risk 
Factors for Canine Mammary Tumours. Acta Veterinaria Brunensis. 74: 103-109.
